The European Commission has published the Horizon Europe Work Programmes for 2026–2027, confirming EUR 14 billion in EU investment to support research and innovation across Europe over the next two years. In line with the EUDA mandate (1), we have reviewed the programmes and identified a set of upcoming Horizon Europe calls of relevance to drug-related research and innovation. These calls span multiple parts of the programme, including:
Cluster 1: Health — addressing prevention, mental health, non-communicable diseases and health systems.
Cluster 3: Civil Security for Society — including…
Read more
This week, the European Union Drugs Agency (EUDA) welcomes its new Executive Director Dr Lorraine Nolan (Ireland), as she begins a five-year term leading the agency.
Dr Nolan was elected to the position by the EUDA Management Board in June 2025, following a competitive public recruitment process launched in September 2024.
Dr Nolan brings over 25 years of senior leadership experience across science, public service and regulatory affairs, including 10 years as Chief Executive of Ireland’s Health Products Regulatory Authority (HPRA). Her career spans national, European and international roles…
Read more
Every year, thousands of people across Europe require hospital treatment for drug-related poisoning and other acute harms. In a new analysis published today, European Drug Emergencies Network (Euro-DEN Plus): data and analysis, the EUDA provides the latest findings on people who present with acute drug-toxicity to hospital emergency services.
Drawing on data from 29 sentinel hospitals in 19 countries (18 EU Member States plus Norway), the results show that cocaine is the most commonly reported drug in these cases, that men account for three-quarters of the presentations, and that…
Read more
